47166-2025 - Result
Spain – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS EFTRENONACOG ALFA, PEGCETACOPLAN, AVATROMBOPAG, ANAKINRA, VOLANESORSEN, ECULIZUMAB, SELUMETINIB, RAMUCIRUMAB, BARICITINIB, SELPERCATINIB, IXEKIZUMAB, ABEMACICLIB, DOSTARLIMAB, ASCIMINIB, INCLISIRAN, TREPROSTINIL Y TRASTUZUMAB DERUXTECAN, SEGUNDA PARTE LOTES 17-31.
OJ S 16/2025 23/01/2025
Contract or concession award notice – standard regime
Supplies
1. Buyer
1.1.
Buyer
Official name: SERVICIO MURCIANO DE SALUD
Email: manuel.bejarano@carm.es
Legal type of the buyer: Public undertaking, controlled by a central government authority
Activity of the contracting authority: Health
2. Procedure
2.1.
Procedure
Title: SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS EFTRENONACOG ALFA, PEGCETACOPLAN, AVATROMBOPAG, ANAKINRA, VOLANESORSEN, ECULIZUMAB, SELUMETINIB, RAMUCIRUMAB, BARICITINIB, SELPERCATINIB, IXEKIZUMAB, ABEMACICLIB, DOSTARLIMAB, ASCIMINIB, INCLISIRAN, TREPROSTINIL Y TRASTUZUMAB DERUXTECAN, SEGUNDA PARTE LOTES 17-31.
Description: SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS EFTRENONACOG ALFA, PEGCETACOPLAN, AVATROMBOPAG, ANAKINRA, VOLANESORSEN, ECULIZUMAB, SELUMETINIB, RAMUCIRUMAB, BARICITINIB, SELPERCATINIB, IXEKIZUMAB, ABEMACICLIB, DOSTARLIMAB, ASCIMINIB, INCLISIRAN, TREPROSTINIL Y TRASTUZUMAB DERUXTECAN, SEGUNDA PARTE LOTES 17-31.
Procedure identifier: 159380b4-c3c7-4f75-9db5-deeaf5b6ec28
Internal identifier: CS/9999/1101135926/24/EXCL
Type of procedure: Negotiated without prior call for competition
2.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
2.1.2.
Place of performance
Postal address: CALLE CENTRAL 7  
Town: MURCIA
Postcode: 30100
Country subdivision (NUTS): Murcia (ES620)
Country: Spain
2.1.3.
Value
Estimated value excluding VAT: 97 092 217,11 EUR
2.1.4.
General information
Legal basis: 
Directive 2014/24/EU
5. Lot
5.1.
Lot: LOT-0017
Title: ixekizumab 80 mg 1 jeringa precargadas solucion inyectable 1 ml
Description: Suministro de medicamentos exclusivos con principios activos eftrenonacog alfa, pegcetacoplan, avatrombopag, anakinra, volanesorsen, eculizumab, selumetinib, ramucirumab, baricitinib, selpercatinib, ixekizumab, abemaciclib, dostarlimab, asciminib, inclisiran, treprostinil y trastuzumab.
Internal identifier: LOT-0017
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33652300 Immunosuppressive agents
Additional classification (cpv): 33652300 Immunosuppressive agents
5.1.2.
Place of performance
Country subdivision (NUTS): Murcia (ES620)
Country: Spain
5.1.5.
Value
Estimated value excluding VAT: 81 673,65 EUR
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.10.
Award criteria
Criterion: 
Type: Price
Description: Oferta económica
Category of award weight criterion: Weight (points, exact)
Award criterion number: 100
5.1.15.
Techniques
Framework agreement: 
No framework agreement
Information about the dynamic purchasing system: 
No dynamic purchase system
5.1.16.
Further information, mediation and review
Mediation organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Review organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Information about review deadlines: 15 días hábiles desde la publicación de la resolución
Organisation providing additional information about the procurement procedure: SERVICIO MURCIANO DE SALUD
Organisation providing more information on the review procedures: SERVICIO MURCIANO DE SALUD
5.1.
Lot: LOT-0018
Title: ixekizumab 80 mg 1 plumas solucion inyectable 1 ml
Description: Suministro de medicamentos exclusivos con principios activos eftrenonacog alfa, pegcetacoplan, avatrombopag, anakinra, volanesorsen, eculizumab, selumetinib, ramucirumab, baricitinib, selpercatinib, ixekizumab, abemaciclib, dostarlimab, asciminib, inclisiran, treprostinil y trastuzumab.
Internal identifier: LOT-0018
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33652300 Immunosuppressive agents
Additional classification (cpv): 33652300 Immunosuppressive agents
5.1.2.
Place of performance
Country subdivision (NUTS): Murcia (ES620)
Country: Spain
5.1.5.
Value
Estimated value excluding VAT: 2 776 904,10 EUR
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.10.
Award criteria
Criterion: 
Type: Price
Description: Oferta económica
Category of award weight criterion: Weight (points, exact)
Award criterion number: 100
5.1.15.
Techniques
Framework agreement: 
No framework agreement
Information about the dynamic purchasing system: 
No dynamic purchase system
5.1.16.
Further information, mediation and review
Mediation organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Review organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Information about review deadlines: 15 días hábiles desde la publicación de la resolución
Organisation providing additional information about the procurement procedure: SERVICIO MURCIANO DE SALUD
Organisation providing more information on the review procedures: SERVICIO MURCIANO DE SALUD
5.1.
Lot: LOT-0019
Title: ixekizumab 80 mg 2 plumas solucion inyectable 1 ml
Description: Suministro de medicamentos exclusivos con principios activos eftrenonacog alfa, pegcetacoplan, avatrombopag, anakinra, volanesorsen, eculizumab, selumetinib, ramucirumab, baricitinib, selpercatinib, ixekizumab, abemaciclib, dostarlimab, asciminib, inclisiran, treprostinil y trastuzumab.
Internal identifier: LOT-0019
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33652300 Immunosuppressive agents
Additional classification (cpv): 33652300 Immunosuppressive agents
5.1.2.
Place of performance
Country subdivision (NUTS): Murcia (ES620)
Country: Spain
5.1.5.
Value
Estimated value excluding VAT: 7 840 605,60 EUR
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.10.
Award criteria
Criterion: 
Type: Price
Description: Oferta económica
Category of award weight criterion: Weight (points, exact)
Award criterion number: 100
5.1.15.
Techniques
Framework agreement: 
No framework agreement
Information about the dynamic purchasing system: 
No dynamic purchase system
5.1.16.
Further information, mediation and review
Mediation organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Review organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Information about review deadlines: 15 días hábiles desde la publicación de la resolución
Organisation providing additional information about the procurement procedure: SERVICIO MURCIANO DE SALUD
Organisation providing more information on the review procedures: SERVICIO MURCIANO DE SALUD
5.1.
Lot: LOT-0020
Title: Abemaciclib 100 mg 56 comprimidos recubiertos
Description: Suministro de medicamentos exclusivos con principios activos eftrenonacog alfa, pegcetacoplan, avatrombopag, anakinra, volanesorsen, eculizumab, selumetinib, ramucirumab, baricitinib, selpercatinib, ixekizumab, abemaciclib, dostarlimab, asciminib, inclisiran, treprostinil y trastuzumab.
Internal identifier: LOT-0020
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33652100 Antineoplastic agents
Additional classification (cpv): 33652100 Antineoplastic agents
5.1.2.
Place of performance
Country subdivision (NUTS): Murcia (ES620)
Country: Spain
5.1.5.
Value
Estimated value excluding VAT: 1 338 441,30 EUR
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.10.
Award criteria
Criterion: 
Type: Price
Description: Oferta económica
Category of award weight criterion: Weight (points, exact)
Award criterion number: 100
5.1.15.
Techniques
Framework agreement: 
No framework agreement
Information about the dynamic purchasing system: 
No dynamic purchase system
5.1.16.
Further information, mediation and review
Mediation organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Review organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Information about review deadlines: 15 días hábiles desde la publicación de la resolución
Organisation providing additional information about the procurement procedure: SERVICIO MURCIANO DE SALUD
Organisation providing more information on the review procedures: SERVICIO MURCIANO DE SALUD
5.1.
Lot: LOT-0021
Title: abemaciclib 150 mg 56 comprimidos recubiertos
Description: Suministro de medicamentos exclusivos con principios activos eftrenonacog alfa, pegcetacoplan, avatrombopag, anakinra, volanesorsen, eculizumab, selumetinib, ramucirumab, baricitinib, selpercatinib, ixekizumab, abemaciclib, dostarlimab, asciminib, inclisiran, treprostinil y trastuzumab.
Internal identifier: LOT-0021
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33652100 Antineoplastic agents
Additional classification (cpv): 33652100 Antineoplastic agents
5.1.2.
Place of performance
Country subdivision (NUTS): Murcia (ES620)
Country: Spain
5.1.5.
Value
Estimated value excluding VAT: 2 676 882,60 EUR
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.10.
Award criteria
Criterion: 
Type: Price
Description: Oferta económica
Category of award weight criterion: Weight (points, exact)
Award criterion number: 100
5.1.15.
Techniques
Framework agreement: 
No framework agreement
Information about the dynamic purchasing system: 
No dynamic purchase system
5.1.16.
Further information, mediation and review
Mediation organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Review organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Information about review deadlines: 15 días hábiles desde la publicación de la resolución
Organisation providing additional information about the procurement procedure: SERVICIO MURCIANO DE SALUD
Organisation providing more information on the review procedures: SERVICIO MURCIANO DE SALUD
5.1.
Lot: LOT-0022
Title: Abemaciclib 50 mg 56 comprimidos recubiertos
Description: Suministro de medicamentos exclusivos con principios activos eftrenonacog alfa, pegcetacoplan, avatrombopag, anakinra, volanesorsen, eculizumab, selumetinib, ramucirumab, baricitinib, selpercatinib, ixekizumab, abemaciclib, dostarlimab, asciminib, inclisiran, treprostinil y trastuzumab.
Internal identifier: LOT-0022
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33652100 Antineoplastic agents
Additional classification (cpv): 33652100 Antineoplastic agents
5.1.2.
Place of performance
Country subdivision (NUTS): Murcia (ES620)
Country: Spain
5.1.5.
Value
Estimated value excluding VAT: 573 617,70 EUR
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.10.
Award criteria
Criterion: 
Type: Price
Description: Oferta económica
Category of award weight criterion: Weight (points, exact)
Award criterion number: 100
5.1.15.
Techniques
Framework agreement: 
No framework agreement
Information about the dynamic purchasing system: 
No dynamic purchase system
5.1.16.
Further information, mediation and review
Mediation organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Review organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Information about review deadlines: 15 días hábiles desde la publicación de la resolución
Organisation providing additional information about the procurement procedure: SERVICIO MURCIANO DE SALUD
Organisation providing more information on the review procedures: SERVICIO MURCIANO DE SALUD
5.1.
Lot: LOT-0023
Title: Dostarlimab 500 mg vial concentrado sol perfusion
Description: Suministro de medicamentos exclusivos con principios activos eftrenonacog alfa, pegcetacoplan, avatrombopag, anakinra, volanesorsen, eculizumab, selumetinib, ramucirumab, baricitinib, selpercatinib, ixekizumab, abemaciclib, dostarlimab, asciminib, inclisiran, treprostinil y trastuzumab.
Internal identifier: LOT-0023
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33652100 Antineoplastic agents
Additional classification (cpv): 33652100 Antineoplastic agents
5.1.2.
Place of performance
Country subdivision (NUTS): Murcia (ES620)
Country: Spain
5.1.5.
Value
Estimated value excluding VAT: 421 453,13 EUR
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.10.
Award criteria
Criterion: 
Type: Price
Description: Oferta económica
Category of award weight criterion: Weight (points, exact)
Award criterion number: 100
5.1.15.
Techniques
Framework agreement: 
No framework agreement
Information about the dynamic purchasing system: 
No dynamic purchase system
5.1.16.
Further information, mediation and review
Mediation organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Review organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Information about review deadlines: 15 días hábiles desde la publicación de la resolución
Organisation providing additional information about the procurement procedure: SERVICIO MURCIANO DE SALUD
Organisation providing more information on the review procedures: SERVICIO MURCIANO DE SALUD
5.1.
Lot: LOT-0024
Title: Asciminib 20 mg 60 comprimidos recubiertos pelicula
Description: Suministro de medicamentos exclusivos con principios activos eftrenonacog alfa, pegcetacoplan, avatrombopag, anakinra, volanesorsen, eculizumab, selumetinib, ramucirumab, baricitinib, selpercatinib, ixekizumab, abemaciclib, dostarlimab, asciminib, inclisiran, treprostinil y trastuzumab.
Internal identifier: LOT-0024
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33652100 Antineoplastic agents
Additional classification (cpv): 33652100 Antineoplastic agents
5.1.2.
Place of performance
Country subdivision (NUTS): Murcia (ES620)
Country: Spain
5.1.5.
Value
Estimated value excluding VAT: 414 854,46 EUR
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.10.
Award criteria
Criterion: 
Type: Price
Description: Oferta económica
Category of award weight criterion: Weight (points, exact)
Award criterion number: 100
5.1.15.
Techniques
Framework agreement: 
No framework agreement
Information about the dynamic purchasing system: 
No dynamic purchase system
5.1.16.
Further information, mediation and review
Mediation organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Review organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Information about review deadlines: 15 días hábiles desde la publicación de la resolución
Organisation providing additional information about the procurement procedure: SERVICIO MURCIANO DE SALUD
Organisation providing more information on the review procedures: SERVICIO MURCIANO DE SALUD
5.1.
Lot: LOT-0025
Title: Asciminib 40 mg 60 comprimidos recubiertos pelicula
Description: Suministro de medicamentos exclusivos con principios activos eftrenonacog alfa, pegcetacoplan, avatrombopag, anakinra, volanesorsen, eculizumab, selumetinib, ramucirumab, baricitinib, selpercatinib, ixekizumab, abemaciclib, dostarlimab, asciminib, inclisiran, treprostinil y trastuzumab.
Internal identifier: LOT-0025
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33652100 Antineoplastic agents
Additional classification (cpv): 33652100 Antineoplastic agents
5.1.2.
Place of performance
Country subdivision (NUTS): Murcia (ES620)
Country: Spain
5.1.5.
Value
Estimated value excluding VAT: 1 037 136,15 EUR
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.10.
Award criteria
Criterion: 
Type: Price
Description: Oferta económica
Category of award weight criterion: Weight (points, exact)
Award criterion number: 100
5.1.15.
Techniques
Framework agreement: 
No framework agreement
Information about the dynamic purchasing system: 
No dynamic purchase system
5.1.16.
Further information, mediation and review
Mediation organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Review organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Information about review deadlines: 15 días hábiles desde la publicación de la resolución
Organisation providing additional information about the procurement procedure: SERVICIO MURCIANO DE SALUD
Organisation providing more information on the review procedures: SERVICIO MURCIANO DE SALUD
5.1.
Lot: LOT-0026
Title: inclisiran 284mg 1 jeringa precargada en 1,5ml de solucion inyectable
Description: Suministro de medicamentos exclusivos con principios activos eftrenonacog alfa, pegcetacoplan, avatrombopag, anakinra, volanesorsen, eculizumab, selumetinib, ramucirumab, baricitinib, selpercatinib, ixekizumab, abemaciclib, dostarlimab, asciminib, inclisiran, treprostinil y trastuzumab.
Internal identifier: LOT-0026
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33690000 Various medicinal products
Additional classification (cpv): 33690000 Various medicinal products
5.1.2.
Place of performance
Country subdivision (NUTS): Murcia (ES620)
Country: Spain
5.1.5.
Value
Estimated value excluding VAT: 481 496,40 EUR
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.10.
Award criteria
Criterion: 
Type: Price
Description: Oferta económica
Category of award weight criterion: Weight (points, exact)
Award criterion number: 100
5.1.15.
Techniques
Framework agreement: 
No framework agreement
Information about the dynamic purchasing system: 
No dynamic purchase system
5.1.16.
Further information, mediation and review
Mediation organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Review organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Information about review deadlines: 15 días hábiles desde la publicación de la resolución
Organisation providing additional information about the procurement procedure: SERVICIO MURCIANO DE SALUD
Organisation providing more information on the review procedures: SERVICIO MURCIANO DE SALUD
5.1.
Lot: LOT-0027
Title: Treprostinil 5 mg/ml solucion para perfusion 1 vial de 10 ml
Description: Suministro de medicamentos exclusivos con principios activos eftrenonacog alfa, pegcetacoplan, avatrombopag, anakinra, volanesorsen, eculizumab, selumetinib, ramucirumab, baricitinib, selpercatinib, ixekizumab, abemaciclib, dostarlimab, asciminib, inclisiran, treprostinil y trastuzumab.
Internal identifier: LOT-0027
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33621100 Antithrombotic agents
Additional classification (cpv): 33621100 Antithrombotic agents
5.1.2.
Place of performance
Country subdivision (NUTS): Murcia (ES620)
Country: Spain
5.1.5.
Value
Estimated value excluding VAT: 217 392,07 EUR
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.10.
Award criteria
Criterion: 
Type: Price
Description: Oferta económica
Category of award weight criterion: Weight (points, exact)
Award criterion number: 100
5.1.15.
Techniques
Framework agreement: 
No framework agreement
Information about the dynamic purchasing system: 
No dynamic purchase system
5.1.16.
Further information, mediation and review
Mediation organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Review organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Information about review deadlines: 15 días hábiles desde la publicación de la resolución
Organisation providing additional information about the procurement procedure: SERVICIO MURCIANO DE SALUD
Organisation providing more information on the review procedures: SERVICIO MURCIANO DE SALUD
5.1.
Lot: LOT-0028
Title: Treprostinil 1 mg/ml solucion para perfusion 1 vial de 10 ml
Description: Suministro de medicamentos exclusivos con principios activos eftrenonacog alfa, pegcetacoplan, avatrombopag, anakinra, volanesorsen, eculizumab, selumetinib, ramucirumab, baricitinib, selpercatinib, ixekizumab, abemaciclib, dostarlimab, asciminib, inclisiran, treprostinil y trastuzumab.
Internal identifier: LOT-0028
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33621100 Antithrombotic agents
Additional classification (cpv): 33621100 Antithrombotic agents
5.1.2.
Place of performance
Country subdivision (NUTS): Murcia (ES620)
Country: Spain
5.1.5.
Value
Estimated value excluding VAT: 9 937,94 EUR
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.10.
Award criteria
Criterion: 
Type: Price
Description: Oferta económica
Category of award weight criterion: Weight (points, exact)
Award criterion number: 100
5.1.15.
Techniques
Framework agreement: 
No framework agreement
Information about the dynamic purchasing system: 
No dynamic purchase system
5.1.16.
Further information, mediation and review
Mediation organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Review organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Information about review deadlines: 15 días hábiles desde la publicación de la resolución
Organisation providing additional information about the procurement procedure: SERVICIO MURCIANO DE SALUD
Organisation providing more information on the review procedures: SERVICIO MURCIANO DE SALUD
5.1.
Lot: LOT-0029
Title: Treprostinil 2,5 mg/ml solucion para perfusion 1 vial de 10 ml
Description: Suministro de medicamentos exclusivos con principios activos eftrenonacog alfa, pegcetacoplan, avatrombopag, anakinra, volanesorsen, eculizumab, selumetinib, ramucirumab, baricitinib, selpercatinib, ixekizumab, abemaciclib, dostarlimab, asciminib, inclisiran, treprostinil y trastuzumab.
Internal identifier: LOT-0029
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33621100 Antithrombotic agents
Additional classification (cpv): 33621100 Antithrombotic agents
5.1.2.
Place of performance
Country subdivision (NUTS): Murcia (ES620)
Country: Spain
5.1.5.
Value
Estimated value excluding VAT: 49 689,72 EUR
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.10.
Award criteria
Criterion: 
Type: Price
Description: Oferta económica
Category of award weight criterion: Weight (points, exact)
Award criterion number: 100
5.1.15.
Techniques
Framework agreement: 
No framework agreement
Information about the dynamic purchasing system: 
No dynamic purchase system
5.1.16.
Further information, mediation and review
Mediation organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Review organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Information about review deadlines: 15 días hábiles desde la publicación de la resolución
Organisation providing additional information about the procurement procedure: SERVICIO MURCIANO DE SALUD
Organisation providing more information on the review procedures: SERVICIO MURCIANO DE SALUD
5.1.
Lot: LOT-0030
Title: Treprostinil 10 mg/ml solucion para perfusion 1 vial de 10 ml
Description: Suministro de medicamentos exclusivos con principios activos eftrenonacog alfa, pegcetacoplan, avatrombopag, anakinra, volanesorsen, eculizumab, selumetinib, ramucirumab, baricitinib, selpercatinib, ixekizumab, abemaciclib, dostarlimab, asciminib, inclisiran, treprostinil y trastuzumab.
Internal identifier: LOT-0030
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33621100 Antithrombotic agents
Additional classification (cpv): 33621100 Antithrombotic agents
5.1.2.
Place of performance
Country subdivision (NUTS): Murcia (ES620)
Country: Spain
5.1.5.
Value
Estimated value excluding VAT: 248 448,60 EUR
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.10.
Award criteria
Criterion: 
Type: Price
Description: Oferta económica
Category of award weight criterion: Weight (points, exact)
Award criterion number: 100
5.1.15.
Techniques
Framework agreement: 
No framework agreement
Information about the dynamic purchasing system: 
No dynamic purchase system
5.1.16.
Further information, mediation and review
Mediation organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Review organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Information about review deadlines: 15 días hábiles desde la publicación de la resolución
Organisation providing additional information about the procurement procedure: SERVICIO MURCIANO DE SALUD
Organisation providing more information on the review procedures: SERVICIO MURCIANO DE SALUD
5.1.
Lot: LOT-0031
Title: Trastuzumab deruxtecan 100 mg vial polvo concentrado perfusion
Description: Suministro de medicamentos exclusivos con principios activos eftrenonacog alfa, pegcetacoplan, avatrombopag, anakinra, volanesorsen, eculizumab, selumetinib, ramucirumab, baricitinib, selpercatinib, ixekizumab, abemaciclib, dostarlimab, asciminib, inclisiran, treprostinil y trastuzumab.
Internal identifier: LOT-0031
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33652100 Antineoplastic agents
Additional classification (cpv): 33652100 Antineoplastic agents
5.1.2.
Place of performance
Country subdivision (NUTS): Murcia (ES620)
Country: Spain
5.1.5.
Value
Estimated value excluding VAT: 9 057 636,00 EUR
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.10.
Award criteria
Criterion: 
Type: Price
Description: Oferta económica
Category of award weight criterion: Weight (points, exact)
Award criterion number: 100
5.1.15.
Techniques
Framework agreement: 
No framework agreement
Information about the dynamic purchasing system: 
No dynamic purchase system
5.1.16.
Further information, mediation and review
Mediation organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Review organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Information about review deadlines: 15 días hábiles desde la publicación de la resolución
Organisation providing additional information about the procurement procedure: SERVICIO MURCIANO DE SALUD
Organisation providing more information on the review procedures: SERVICIO MURCIANO DE SALUD
6. Results
Value of all contracts awarded in this notice: 9 998 386,72 EUR
Direct award: 
Justification for direct award: The contract can be provided only by a particular economic operator because of exclusive rights, including intellectual property rights
Other justification: El procedimiento es negociado sin publicidad, ya que solamente puede encomendarse el objeto del presente contrato por tratarse de derechos exclusivos de varios laboratorios farmacéuticos.
6.1.
Result lot identifier: LOT-0017
Winner selection status: At least one winner was chosen.
6.1.2.
Information about winners
Winner: 
Official name: LILLY, S.A.
Tender: 
Tender identifier: OFERTA-17
Identifier of lot or group of lots: LOT-0017
Value of the tender: 30 249,50 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: LOT-0017
Title: SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS SEGUNDA PARTE LOTES 17-31
Date on which the winner was chosen: 08/01/2025
6.1.4.
Statistical information
Received tenders or requests to participate: 
Type of received submissions: Tenders submitted electronically
Number of tenders or requests to participate received: 1
6.1.
Result lot identifier: LOT-0018
Winner selection status: At least one winner was chosen.
6.1.2.
Information about winners
Winner: 
Official name: LILLY, S.A.
Tender: 
Tender identifier: OFERTA-18
Identifier of lot or group of lots: LOT-0018
Value of the tender: 1 028 483,00 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: LOT-0018
Title: SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS SEGUNDA PARTE LOTES 17-31
Date on which the winner was chosen: 08/01/2025
6.1.4.
Statistical information
Received tenders or requests to participate: 
Type of received submissions: Tenders submitted electronically
Number of tenders or requests to participate received: 1
6.1.
Result lot identifier: LOT-0019
Winner selection status: At least one winner was chosen.
6.1.2.
Information about winners
Winner: 
Official name: LILLY, S.A.
Tender: 
Tender identifier: OFERTA-19
Identifier of lot or group of lots: LOT-0019
Value of the tender: 2 903 928,00 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: LOT-0019
Title: SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS SEGUNDA PARTE LOTES 17-31
Date on which the winner was chosen: 08/01/2025
6.1.4.
Statistical information
Received tenders or requests to participate: 
Type of received submissions: Tenders submitted electronically
Number of tenders or requests to participate received: 1
6.1.
Result lot identifier: LOT-0020
Winner selection status: At least one winner was chosen.
6.1.2.
Information about winners
Winner: 
Official name: LILLY, S.A.
Tender: 
Tender identifier: OFERTA-20
Identifier of lot or group of lots: LOT-0020
Value of the tender: 495 719,00 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: LOT-0020
Title: SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS SEGUNDA PARTE LOTES 17-31
Date on which the winner was chosen: 08/01/2025
6.1.4.
Statistical information
Received tenders or requests to participate: 
Type of received submissions: Tenders submitted electronically
Number of tenders or requests to participate received: 1
6.1.
Result lot identifier: LOT-0021
Winner selection status: At least one winner was chosen.
6.1.2.
Information about winners
Winner: 
Official name: LILLY, S.A.
Tender: 
Tender identifier: OFERTA-21
Identifier of lot or group of lots: LOT-0021
Value of the tender: 991 438,00 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: LOT-0021
Title: SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS SEGUNDA PARTE LOTES 17-31
Date on which the winner was chosen: 08/01/2025
6.1.4.
Statistical information
Received tenders or requests to participate: 
Type of received submissions: Tenders submitted electronically
Number of tenders or requests to participate received: 1
6.1.
Result lot identifier: LOT-0022
Winner selection status: At least one winner was chosen.
6.1.2.
Information about winners
Winner: 
Official name: LILLY, S.A.
Tender: 
Tender identifier: OFERTA-22
Identifier of lot or group of lots: LOT-0022
Value of the tender: 212 451,00 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: LOT-0022
Title: SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS SEGUNDA PARTE LOTES 17-31
Date on which the winner was chosen: 08/01/2025
6.1.4.
Statistical information
Received tenders or requests to participate: 
Type of received submissions: Tenders submitted electronically
Number of tenders or requests to participate received: 1
6.1.
Result lot identifier: LOT-0023
Winner selection status: At least one winner was chosen.
6.1.2.
Information about winners
Winner: 
Official name: GLAXOSMITH KLINE, S.A
Tender: 
Tender identifier: OFERTA-23
Identifier of lot or group of lots: LOT-0023
Value of the tender: 156 093,75 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: LOT-0023
Title: SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS SEGUNDA PARTE LOTES 17-31
Date on which the winner was chosen: 08/01/2025
6.1.4.
Statistical information
Received tenders or requests to participate: 
Type of received submissions: Tenders submitted electronically
Number of tenders or requests to participate received: 1
6.1.
Result lot identifier: LOT-0024
Winner selection status: At least one winner was chosen.
6.1.2.
Information about winners
Winner: 
Official name: NOVARTIS FARMACEUTICA, S.A.
Tender: 
Tender identifier: OFERTA-24
Identifier of lot or group of lots: LOT-0024
Value of the tender: 153 649,80 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: LOT-0024
Title: SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS SEGUNDA PARTE LOTES 17-31
Date on which the winner was chosen: 08/01/2025
6.1.4.
Statistical information
Received tenders or requests to participate: 
Type of received submissions: Tenders submitted electronically
Number of tenders or requests to participate received: 1
6.1.
Result lot identifier: LOT-0025
Winner selection status: At least one winner was chosen.
6.1.2.
Information about winners
Winner: 
Official name: NOVARTIS FARMACEUTICA, S.A.
Tender: 
Tender identifier: OFERTA-25
Identifier of lot or group of lots: LOT-0025
Value of the tender: 384 124,50 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: LOT-0025
Title: SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS SEGUNDA PARTE LOTES 17-31
Date on which the winner was chosen: 08/01/2025
6.1.4.
Statistical information
Received tenders or requests to participate: 
Type of received submissions: Tenders submitted electronically
Number of tenders or requests to participate received: 1
6.1.
Result lot identifier: LOT-0026
Winner selection status: At least one winner was chosen.
6.1.2.
Information about winners
Winner: 
Official name: NOVARTIS FARMACEUTICA, S.A.
Tender: 
Tender identifier: OFERTA-26
Identifier of lot or group of lots: LOT-0026
Value of the tender: 178 332,00 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: LOT-0026
Title: SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS SEGUNDA PARTE LOTES 17-31
Date on which the winner was chosen: 08/01/2025
6.1.4.
Statistical information
Received tenders or requests to participate: 
Type of received submissions: Tenders submitted electronically
Number of tenders or requests to participate received: 1
6.1.
Result lot identifier: LOT-0027
Winner selection status: At least one winner was chosen.
6.1.2.
Information about winners
Winner: 
Official name: AOP ORPHAN PHARMACEUTICALS IBERIA, S.L.
Tender: 
Tender identifier: OFERTA-27
Identifier of lot or group of lots: LOT-0027
Value of the tender: 80 515,58 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: LOT-0027
Title: SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS SEGUNDA PARTE LOTES 17-31
Date on which the winner was chosen: 08/01/2025
6.1.4.
Statistical information
Received tenders or requests to participate: 
Type of received submissions: Tenders submitted electronically
Number of tenders or requests to participate received: 1
6.1.
Result lot identifier: LOT-0028
Winner selection status: At least one winner was chosen.
6.1.2.
Information about winners
Winner: 
Official name: AOP ORPHAN PHARMACEUTICALS IBERIA, S.L.
Tender: 
Tender identifier: OFERTA-28
Identifier of lot or group of lots: LOT-0028
Value of the tender: 178 332,00 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: LOT-0028
Title: SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS SEGUNDA PARTE LOTES 17-31
Date on which the winner was chosen: 08/01/2025
6.1.4.
Statistical information
Received tenders or requests to participate: 
Type of received submissions: Tenders submitted electronically
Number of tenders or requests to participate received: 1
6.1.
Result lot identifier: LOT-0029
Winner selection status: At least one winner was chosen.
6.1.2.
Information about winners
Winner: 
Official name: AOP ORPHAN PHARMACEUTICALS IBERIA, S.L.
Tender: 
Tender identifier: OFERTA-29
Identifier of lot or group of lots: LOT-0029
Value of the tender: 178 332,00 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: LOT-0029
Title: SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS SEGUNDA PARTE LOTES 17-31
Date on which the winner was chosen: 08/01/2025
6.1.4.
Statistical information
Received tenders or requests to participate: 
Type of received submissions: Tenders submitted electronically
Number of tenders or requests to participate received: 1
6.1.
Result lot identifier: LOT-0030
Winner selection status: At least one winner was chosen.
6.1.2.
Information about winners
Winner: 
Official name: AOP ORPHAN PHARMACEUTICALS IBERIA, S.L.
Tender: 
Tender identifier: OFERTA-30
Identifier of lot or group of lots: LOT-0030
Value of the tender: 178 332,00 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: LOT-0030
Title: SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS SEGUNDA PARTE LOTES 17-31
Date on which the winner was chosen: 08/01/2025
6.1.4.
Statistical information
Received tenders or requests to participate: 
Type of received submissions: Tenders submitted electronically
Number of tenders or requests to participate received: 1
6.1.
Result lot identifier: LOT-0031
Winner selection status: At least one winner was chosen.
6.1.2.
Information about winners
Winner: 
Official name: DAIICHI-SANKYO, S.A
Tender: 
Tender identifier: OFERTA-31
Identifier of lot or group of lots: LOT-0031
Value of the tender: 178 332,00 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: LOT-0031
Title: SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS SEGUNDA PARTE LOTES 17-31
Date on which the winner was chosen: 08/01/2025
6.1.4.
Statistical information
Received tenders or requests to participate: 
Type of received submissions: Tenders submitted electronically
Number of tenders or requests to participate received: 1
8. Organisations
8.1.
ORG-0001
Official name: SERVICIO MURCIANO DE SALUD
Registration number: Q8050008E
Postal address: Central, nº7 Edificio Habitamia. 6ª planta. Espinardo
Town: Murcia
Postcode: 30100
Country subdivision (NUTS): Murcia (ES620)
Country: Spain
Contact point: Manuel Bejarano García
Email: manuel.bejarano@carm.es
Telephone: 968288079
Internet address: www.murciasalud.es
Roles of this organisation: 
Buyer
Organisation providing additional information about the procurement procedure
Organisation providing more information on the review procedures
8.1.
ORG-0002
Official name: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Registration number: Q6152336Z
Postal address: Avenida General Peron 38
Town: Madrid
Postcode: 28071
Country subdivision (NUTS): Madrid (ES300)
Country: Spain
Email: tribunal_recursos.contratos@hacienda.gob.es
Telephone: 91 3491451
Roles of this organisation: 
Review organisation
Mediation organisation
8.1.
ORG-0005
Official name: LILLY, S.A.
Registration number: A28058386
Postal address: CALLE INDUSTRIA, 30
Town: ALCOBENDAS
Postcode: 28100
Country subdivision (NUTS): Madrid (ES300)
Country: Spain
Email: ar.spain@lilly.com
Telephone: 902 338300
Roles of this organisation: 
Tenderer
Winner of these lots: LOT-0017, LOT-0018, LOT-0019, LOT-0020, LOT-0021, LOT-0022
8.1.
ORG-0006
Official name: GLAXOSMITH KLINE, S.A
Registration number: A28228526
Postal address: CALLE SEVERO OCHOA,2
Town: TRES CANTOS
Postcode: 28760
Country subdivision (NUTS): Madrid (ES300)
Country: Spain
Email: O2C.Spain@gsk.com
Telephone: 918075278
Roles of this organisation: 
Tenderer
Winner of these lots: LOT-0023
8.1.
ORG-0007
Official name: NOVARTIS FARMACEUTICA, S.A.
Registration number: A08011074
Postal address: GRAN VIA DE LES CORTS CATALANES, 764
Town: BARCELONA
Postcode: 08013
Country subdivision (NUTS): Barcelona (ES511)
Country: Spain
Email: hector.moyano_flores@novartis.com
Telephone: 933064200
Roles of this organisation: 
Tenderer
Winner of these lots: LOT-0024, LOT-0025, LOT-0026
8.1.
ORG-0008
Official name: AOP ORPHAN PHARMACEUTICALS IBERIA, S.L.
Registration number: B88360870
Postal address: CALLE AGUSTIN DE BETANCOURT, 3ª
Town: MADRID
Postcode: 28003
Country subdivision (NUTS): Madrid (ES300)
Country: Spain
Email: purificacion.gonzalez@aoporphan.com
Telephone: 626833433
Roles of this organisation: 
Tenderer
Winner of these lots: LOT-0027, LOT-0028, LOT-0029, LOT-0030
8.1.
ORG-0009
Official name: DAIICHI-SANKYO, S.A
Registration number: A28134856
Postal address: CALLE ACANTO, PLANTA 9
Town: MADRID
Postcode: 28045
Country subdivision (NUTS): Madrid (ES300)
Country: Spain
Email: info@daiichi-sankyo.es
Telephone: 915399911
Roles of this organisation: 
Tenderer
Winner of these lots: LOT-0031
8.1.
ORG-0000
Official name: Publications Office of the European Union
Registration number: PUBL
Town: Luxembourg
Postcode: 2417
Country subdivision (NUTS): Luxembourg (LU000)
Country: Luxembourg
Email: ted@publications.europa.eu
Telephone: +352 29291
Internet address: https://op.europa.eu
Roles of this organisation: 
TED eSender
Notice information
Notice identifier/version: 2797b1dc-9ce4-4ccf-ba1b-b0a0ceef3093  -  01
Form type: Result
Notice type: Contract or concession award notice – standard regime
Notice subtype: 29
Notice dispatch date: 22/01/2025 12:01:10 (UTC+00:00) Western European Time, GMT
Languages in which this notice is officially available: Spanish
Notice publication number: 47166-2025
OJ S issue number: 16/2025
Publication date: 23/01/2025